(Q57417579)

English

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma

No description defined

In more languages

Statements

scholarly article

0 references

Improved systemic safety and risk–benefit ratio of topical 0.1% timolol hydrogel compared with 0.5% timolol aqueous solution in the treatment of glaucoma (English)

0 references

1 reference

based on heuristic

inferred from title

object named as

Mika Kähönen

2

0 references

1

object named as

Hannu Uusitalo

0 references

author name string

Auli Ropo

3

0 references

Jukka Mäenpää

4

0 references

Gunilla Bjärnhall

5

0 references

Hans Hedenström

6

0 references

Väinö Turjanmaa

7

0 references

publication date

21 April 2006

0 references

Graefe's Archive for Clinical and Experimental Ophthalmology

0 references

244

0 references

11

0 references

1491-1496

0 references

Systemic effects of medications used to treat glaucoma

1 reference

https://api.crossref.org/works/10.1007%2FS00417-006-0328-0

21 January 2018

Comparison of the effects of aqueous and gellan ophthalmic timolol on peak exercise performance in middle-aged men

1 reference

https://api.crossref.org/works/10.1007%2FS00417-006-0328-0

21 January 2018

Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.

1 reference

https://api.crossref.org/works/10.1007%2FS00417-006-0328-0

21 January 2018

Cardiovascular effects of ophthalmic 0.5% timolol aqueous solution and 0.1% timolol hydrogel

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timolol: short term "escape" and long term "drift"

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of a novel hydrogel formulation in human volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global data on blindness

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of aqueous and gellan ophthalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and systemic side-effects of topical 0.5% timolol aqueous solution and 0.1% timolol hydrogel

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-blocker eyedrops and nocturnal arterial hypotension

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timolol 0.1% gel (Nyogel 0.1% once daily versus conventional timolol 0.5% solution twice daily: a comparison of efficacy and safety

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16628416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00417-006-0328-0

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57417579&oldid=2213459590"